期刊文献+

碧迪FACS CantoⅡ流式细胞仪性能评价及实验室应用 被引量:4

Evaluation and Clinical Application of BD FACS Canto Ⅱ Flow Cytometer
下载PDF
导出
摘要 目的评估碧迪FACS CantoⅡ(BD FACS CantoⅡ)流式细胞仪的性能及实验室应用。方法依据中华人民共和国医药行业新版标准《YY/T0588-2017流式细胞仪》^([1])对BD FACS CantoⅡ流式细胞仪进行性能评价,评价内容包括:荧光检出限、荧光线性、前向角散射光(forward scatter resolution,FSC)检出限、仪器分辨率、FSC分辨率、侧向角散射光(side scattering resolution,SSC)分辨率、倍体分析线性、表面标志物检测的准确度、表面标志物检测的重复性、携带污染率和仪器稳定性。完成性能评价后,分别用BD FACS CantoⅡ流式细胞仪及其配套的BD六色淋巴细胞亚群试剂盒和BD FACS Calibur流式细胞仪及其配套的BD四色淋巴细胞亚群试剂盒分别检测20份全血标本,比较两台仪器在标本前处理、上机检测、分析结果所用时间和结果比较的差异。结果该流式细胞仪对异硫氰酸荧光素(fluorescein isothiocyanate,FITC)通道荧光检出限为40.18等量可溶性荧光分子数(molecules equiva-lent soluble fluorochrome,MESF),对藻红蛋白(P-phycoerythrin,PE)通道荧光检出限为23.77 MESF,两者的决定系数(R square,r)均为0.999 9;FSC最小可检测0.22μm微球;仪器分辨率FSC,FITC和PE荧光通道的变异系数(coeffivirnt of cariation,CV)分别为2.3%,2.4%和2.4%;FSC/SSC散点图可明显区分外周血中红细胞和血小板,同时能区分白细胞中的淋巴细胞、中性粒细胞、单核细胞;倍体分析线性中G_2/M期(四倍体细胞峰)与G_0/G_1期(二倍体细胞峰)的平均荧光强度比值为1.98;表面标志物检测值的平均值均在质控品说明书给定的靶值参考范围内;表面标志物检测重复性CV分别为CD3:2.75%,CD4:1.86%,CD8:5.14%,CD16/CD56:7.33%和CD19:11.26%;携带污染率最大为0.05%;该仪器开机8 h检测FSC及各荧光通道峰值荧光道数偏差值(B)分别为-0.40%,-0.55%,1.57%,1.88%,1.66%,7.44%,7.23%,6.63%和6.21%;BD FACS CantoⅡ流式细胞仪及其配套试剂盒较BD FACS Ca Objective To evaluate the performance of BD FACS CantoⅡflow cytometer.Methods According to the latest medicine industry standard of the People’s Republic of China《YY/T0588-2017flow cytometry》[1],evaluated the performance of flow cytometry such as fluorescence sensitivity,fluorescence linearity,forward scatter sensitivity(FSC),instrument resolution,forward scatter/side scattering resolution(SSC),DNA content linearity,carry-over rate,accuracy of the cell surface marker,reproducibility of the cell surface marker,instrument stability and clinical application.After the evaluation,used the BD FACS CantoⅡand supporting the BD Multitest TM6-color TBNK Reagent and BD FACS Calibur flow cytometer and supporting the BD Multitest TMIMK Kit,than testing 20cases of whole blood samples.Results The fluorescence detection limit was 40.18molecules equiva-lent soluble fluorochrome(MESF)of fluorescein isothiocyanate(FITC)channel and 23.77 MESF of P-phycoerythrin(PE)channel,both rvalues were 0.999 9.The detection limit for FSC could detect 0.22μm microspheres,instrument resolution:coeffivirnt of cariation(CV)of FSC,FITE,PE channel were 2.3%,2.4%and 2.4%.The scatter plots of FSC/SSC could distinguish thyrocyte,platelets in peripheral blood,and lymphocytes,neutrophils and monocytes in leukocyte.The average fluorescence intensity ratio of DNA content linearity G0/G1and G2/M was 1.98.The average value of all surface markers was within the reference range.The coefficient of variation of surface marker detection repeatability was CD3:2.75%,CD4:1.86%,CD8:5.14%,CD16/CD56:7.33%and CD19:11.26%,and the carry-overrate up to 0.05%.Instrument stability,the deviation(B)of each fluorescent channel after 8hours of starting was:-0.40%,-0.55%,1.57%,1.88%,1.66%,7.44%,7.23%,6.63%and 6.21%,respectively.Validation results related to clinical applications showed its advantages in effectively improving productivity.The BD FACS CantoⅡflow cytometer and its supporting kit had significantly improved the testing speed compared to the BD FACS Calibur
作者 方佩琪 孙林 顾梅秀 吴蕙 潘柏申 郭玮 王蓓丽 FANG Pei-qi;SUN Lin;GU Mei-xiu;WU Hui;PAN Bai-shen;GUO Wei;WANG Bei-li(Department of Laboratory Medicine,Zhongshan Hospital of Fudan University,Shanghai 200032,China)
出处 《现代检验医学杂志》 CAS 2019年第2期94-99,共6页 Journal of Modern Laboratory Medicine
基金 上海市卫生计生系统重要薄弱学科建设项目(2015ZB0201) 国家自然科学基金(81572064 81772263) 上海市卫生和计划生育委员会科研课题计划任务书(201440389) 上海市科学技术委员会(16411952100)
关键词 BD FACS CantoⅡ 流式细胞仪 性能评价 BD FACS CantoⅡ flowcytometry performance evaluation
  • 相关文献

参考文献9

二级参考文献146

  • 1满秋红,邱立娟,刘铁强,胡楷勋,黄珊,孙雪东.成人急性淋巴细胞白血病免疫表型特点分析[J].中国体视学与图像分析,2008,13(4):268-271. 被引量:3
  • 2刘艳荣,王卉,常艳,程翼飞,付家瑜,张乐萍,刘桂兰,陈珊珊.四色流式细胞术检测急性B淋巴细胞白血病残留细胞[J].中华血液学杂志,2005,26(6):327-331. 被引量:13
  • 3郑春静,吴雄飞,刘东海,张顺.用流式细胞仪检测大黄鱼三倍体[J].细胞生物学杂志,2006,28(2):253-256. 被引量:11
  • 4李乐,伍严安,黄源茂.胸腹水脱落细胞流式细胞法DNA倍体分析的临床诊断价值[J].福建医科大学学报,2007,41(2):159-162. 被引量:5
  • 5San Miguel JF,Gutierrez NC,Mateo G,et al.Conventional diagnostics in multiple myeloma.Eur J Cancer,2006;42(11):1510-1519. 被引量:1
  • 6Raja KR,Kovarova L,Hajek R.Review of phenotypic markers used in flow cytometric analysis of MGUS and MM,and applicability of flow cytometry in other plasma cell disorders.Br J Haematol,2010;149(3):334-351. 被引量:1
  • 7Rawstron AC,Davies FE,DasGupta R,et al.Flow cytometric disease monitoring in multiple myeloma:the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.Blood,2002;100(9):3095-3100. 被引量:1
  • 8Perez-Andres M,Almeida J,Martin-Ayuso M,et al.Clonal plasma cells from monoclonal gammopathy of undetermined significance,multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.Leukemia,2005;19(3):449-455. 被引量:1
  • 9Moreau P,Robillard N,Avet-Loiseau H,et al.Patients with CD45negative multiple myeloma receiving high-dose therapy have it shorter survival than those with CD45 positive multiple myeloma.Haematologica,2004;89(5):547-551. 被引量:1
  • 10Mateo G,Montalbán MA,Vidriales MB,et al.Prognostic value of immunophenotyping in multiple myeloma:a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.J Clin Oncol,2008;26(16):2737-2744. 被引量:1

共引文献91

同被引文献43

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部